Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE) — Stella

Recruiting

Back to Heart Failure trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Australia

Baker Heart and Diabetes Institute, Melbourne, Victoria

Key details

Sponsor

Baker Heart and Diabetes Institute

Enrollment target

~820 participants

Started

November 2021

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years – 85 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov